Regeneron

July 2020 •
52 pages •
Report ID: 5955608 •
Format: PDF

Summary
Table of contents

PharmaVitae explores Regeneron’s prescription pharmaceutical performance and outlook over 2019–29.

Snapshot
Overview – Regeneron’s prescription pharmaceutical business has solid near-term growth but will see a long-term decline due to Eylea biosimilars.
Key themes – [1] Eylea sales will peak in 2022 as biosimilar competition begins in the US in 2023 [2] Collaboration revenue will continue to grow, driven by Dupixent and international Eylea sales.

Model updates (5 May 2020)

Praluent forecast added due to restructuring of Sanofi agreement
Libtayo forecast adjusted higher due to recent trial data from non-small cell lung cancer and basal cell carcinoma.

Model updates (6 February 2020)

Eylea forecast adjusted higher due to continued share gains.

Model updates (8 November 2019)

Eylea forecast adjusted higher due to continued market share gains in wet AMD and diabetic eye conditions
Libtayo forecast adjusted higher due to continued growth in advanced cutaneous squamous cell carcinoma.

Model updates (12 July 2019)

Libtayo sales adjusted higher due to stronger than expected launch.

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

FAQ

Testimonials

The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.

Cristian Nunez

Director of Corporate Development Chugach Alaska Corporation

My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.

D. Lescuyer

Executive Vice President Oral Business at Skyepharma

The research specialist was very helpful, and proposed the best content for my needs. ReportBuyer also offered a great follow-up, thanks for everything !

P. Thompson

EMEA Managing Director

We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.

Y. Wang

Business Analyst

We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.

S. Chen

Research Coordinator

I was impressed by the customer service: it was fast, responsive, and 100% professional !

D. Krivan

Market Research Analyst

The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.

C. Adams

Senior Business Development Manager

Regeneron

Our reports have been used by over 10K customers, including:

Related reports and data

Topic: Prescription Drug

Parent Industry